Results
242
Companies which are more than 50% undervalued based on analyst price target.
242 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WGX | AU$2.54 | -7.6% | 13.4% | AU$2.4b | AU$3.98 | PE25.3x | E37.5% | 1.0% | Materials | ||
WAF | AU$1.65 | 0.9% | 70.1% | AU$1.9b | AU$2.81 | PE12.2x | E29.2% | n/a | Materials | ||
NEU | AU$14.45 | -0.7% | -37.3% | AU$1.8b | AU$27.00 | PE15.6x | E-22.9% | n/a | Pharmaceuticals & Biotech | ||
SPR | AU$1.33 | -8.3% | 181.9% | AU$1.8b | AU$2.15 | PB10.8x | E107.6% | n/a | Materials | ||
NXL New | AU$4.28 | -22.7% | 177.9% | AU$1.5b | AU$6.65 | PE281.6x | E40.3% | n/a | Software | ||
CU6 | AU$3.74 | -7.9% | 64.0% | AU$1.3b | AU$8.67 | PS104.3x | E37.4% | n/a | Pharmaceuticals & Biotech | ||
CRN | AU$0.65 | -9.2% | -59.3% | AU$1.1b | AU$1.10 | PS0.3x | E72.4% | 2.5% | Materials | ||
VUL New | AU$4.66 | -12.9% | 124.0% | AU$1.1b | AU$9.53 | PS21.5x | E19.9% | n/a | Materials | ||
A4N | AU$0.87 | -0.6% | 6.7% | AU$994.3m | AU$1.72 | PS22441.2x | E13.7% | n/a | Materials | ||
RSG | AU$0.41 | -1.2% | 0% | AU$894.2m | AU$0.67 | PE42.3x | E42.5% | 0% | Materials | ||
WA1 | AU$13.00 | -2.1% | 29.7% | AU$880.3m | AU$27.75 | PB12.2x | E52.3% | n/a | Materials | ||
BCI | AU$0.28 | -1.8% | 0% | AU$793.6m | AU$0.49 | PB1x | E23.8% | 0% | Materials | ||
BRN | AU$0.33 | -12.0% | 106.3% | AU$650.9m | AU$1.59 | PS1817.1x | n/a | n/a | Software | ||
DVP | AU$2.47 | 11.3% | 5.1% | AU$638.3m | AU$4.35 | PS4.6x | E90.7% | n/a | Materials | ||
PDI | AU$0.25 | -7.4% | 19.0% | AU$611.2m | AU$0.56 | PS3441.7x | E82.6% | n/a | Materials | ||
CUV | AU$12.20 | 4.4% | -20.9% | AU$602.9m | AU$28.23 | PE17.1x | E26.2% | 0.4% | Pharmaceuticals & Biotech | ||
DRO | AU$0.67 | 1.5% | 29.1% | AU$558.2m | AU$1.15 | PE77.7x | E52.2% | n/a | Capital Goods | ||
BRE | AU$2.14 | -5.3% | 25.9% | AU$557.2m | AU$5.50 | PB5.4x | E44.1% | n/a | Materials | ||
TBN | AU$0.19 | 11.8% | 5.6% | AU$552.4m | AU$0.36 | PB1.2x | E37.6% | n/a | Energy | ||
PYC | AU$1.22 | 15.6% | 38.6% | AU$548.3m | AU$8.75 | PS25.8x | E36.8% | n/a | Pharmaceuticals & Biotech | ||
LOT | AU$0.24 | -4.0% | -30.4% | AU$531.6m | AU$0.53 | PS26800.1x | E71.3% | n/a | Energy | ||
FFM | AU$0.88 | -4.9% | 69.2% | AU$513.1m | AU$1.70 | PB2.7x | E44.8% | n/a | Materials | ||
BMN | AU$2.91 | -8.2% | -16.9% | AU$499.0m | AU$5.87 | PB4.9x | E59.5% | n/a | Energy | ||
IMM | AU$0.35 | 6.1% | 2.9% | AU$494.9m | AU$1.13 | PS132.6x | E1.0% | n/a | Pharmaceuticals & Biotech |